Name: ESC 2018: Cohort study of serious adverse events with SGLT2 inhibitors
Uploaded: 2018-09-04T11:42:43+01:00
Duration: 4 min 13 s
Description: Dr Peter Jakobsson Ueda discusses the cohort study of serious adverse events with SGLT2 inhibitors, filmed by Radcliffe Cardiology on site in Munich, ESC 2018.

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

ESC 2018: Cohort study of serious adverse events with SGLT2 inhibitors

Published: 04 Sep 2018

Views:
522
Likes:
0

Average (ratings)

No ratings

Your rating

Dr Peter Jakobsson Ueda discusses the cohort study of serious adverse events with SGLT2 inhibitors, filmed by Radcliffe Cardiology on site in Munich, ESC 2018.